Display:
Providers:
AbbVie Inc. is a research-based biopharmaceutical company, which is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta; aesthetics products that include Botox Cosmetic, Juvederm Collection and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products consists of Lumigan, Alphagan and Restasis; women's health products include Lo Loestrin, Orilissa and others; and other products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. Its products are sold to wholesalers, government agencies, health care facilities and independent retailers. It also discovers and develop antibody medicines that target difficult-to-drug disease-causing proteins, such as G protein-coupled receptors (GPCRs).
Premarket |
|
|
| ||
Market Hours |
|
|
|
|
|
January 25, 2023 | ||
---|---|---|
January 18, 2023 | ||
January 17, 2023 | ||
January 16, 2023 | ||
January 10, 2023 | ||
January 06, 2023 | ||
January 05, 2023 | ||
January 03, 2023 | ||
December 16, 2022 | ||
December 15, 2022 | ||
December 12, 2022 | ||
December 11, 2022 | ||
December 10, 2022 | ||
December 06, 2022 | ||
December 01, 2022 | ||
November 23, 2022 | ||
Next > |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.